story of the week
Humoral Immune Response Improves Qualitatively After Repeated COVID Vaccination Despite Anti-CD20 Therapy in Patients With MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Multiple Sclerosis (Houndmills, Basingstoke, England)
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations
Mult. Scler. 2023 Mar 28;[EPub Ahead of Print], C Otto, T Schwarz, LM Jeworowski, ML Schmidt, F Walper, F Pache, P Schindler, M Niederschweiberer, A Krumbholz, R Rose, C Drosten, K Ruprecht, VM CormanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.